142 related articles for article (PubMed ID: 9379204)
1. Fluorine-18-fluoromisonidazole radiation dosimetry in imaging studies.
Graham MM; Peterson LM; Link JM; Evans ML; Rasey JS; Koh WJ; Caldwell JH; Krohn KA
J Nucl Med; 1997 Oct; 38(10):1631-6. PubMed ID: 9379204
[TBL] [Abstract][Full Text] [Related]
2. 18F-Fluorothymidine radiation dosimetry in human PET imaging studies.
Vesselle H; Grierson J; Peterson LM; Muzi M; Mankoff DA; Krohn KA
J Nucl Med; 2003 Sep; 44(9):1482-8. PubMed ID: 12960196
[TBL] [Abstract][Full Text] [Related]
3. [18F]fluoroestradiol radiation dosimetry in human PET studies.
Mankoff DA; Peterson LM; Tewson TJ; Link JM; Gralow JR; Graham MM; Krohn KA
J Nucl Med; 2001 Apr; 42(4):679-84. PubMed ID: 11337559
[TBL] [Abstract][Full Text] [Related]
4. 18F-Fluoroerythronitroimidazole radiation dosimetry in cancer studies.
Tolvanen T; Lehtiö K; Kulmala J; Oikonen V; Eskola O; Bergman J; Minn H
J Nucl Med; 2002 Dec; 43(12):1674-80. PubMed ID: 12468519
[TBL] [Abstract][Full Text] [Related]
5. 1-[Carbon-11]-glucose radiation dosimetry and distribution in human imaging studies.
Graham MM; Peterson LM; Muzi M; Graham BB; Spence AM; Link JM; Krohn KA
J Nucl Med; 1998 Oct; 39(10):1805-10. PubMed ID: 9776292
[TBL] [Abstract][Full Text] [Related]
6. Estimation of absorbed dose for 2-[F-18]fluoro-2-deoxy-D-glucose using whole-body positron emission tomography and magnetic resonance imaging.
Deloar HM; Fujiwara T; Shidahara M; Nakamura T; Watabe H; Narita Y; Itoh M; Miyake M; Watanuki S
Eur J Nucl Med; 1998 Jun; 25(6):565-74. PubMed ID: 9618570
[TBL] [Abstract][Full Text] [Related]
7. (S)-4-(3-18F-fluoropropyl)-L-glutamic acid: an 18F-labeled tumor-specific probe for PET/CT imaging--dosimetry.
Smolarz K; Krause BJ; Graner FP; Wagner FM; Hultsch C; Bacher-Stier C; Sparks RB; Ramsay S; Fels LM; Dinkelborg LM; Schwaiger M
J Nucl Med; 2013 Jun; 54(6):861-6. PubMed ID: 23568366
[TBL] [Abstract][Full Text] [Related]
8. PET-based radiation dosimetry in man of 18F-fluorodihydrotestosterone, a new radiotracer for imaging prostate cancer.
Zanzonico PB; Finn R; Pentlow KS; Erdi Y; Beattie B; Akhurst T; Squire O; Morris M; Scher H; McCarthy T; Welch M; Larson SM; Humm JL
J Nucl Med; 2004 Nov; 45(11):1966-71. PubMed ID: 15534070
[TBL] [Abstract][Full Text] [Related]
9. Estimated radiation dose to the newborn in FDG-PET studies.
Ruotsalainen U; Suhonen-Polvi H; Eronen E; Kinnala A; Bergman J; Haaparanta M; Teräs M; Solin O; Wegelius U
J Nucl Med; 1996 Feb; 37(2):387-93. PubMed ID: 8667081
[TBL] [Abstract][Full Text] [Related]
10. Radiation dosimetry of beta-amyloid tracers 11C-PiB and 18F-BAY94-9172.
O'Keefe GJ; Saunder TH; Ng S; Ackerman U; Tochon-Danguy HJ; Chan JG; Gong S; Dyrks T; Lindemann S; Holl G; Dinkelborg L; Villemagne V; Rowe CC
J Nucl Med; 2009 Feb; 50(2):309-15. PubMed ID: 19164222
[TBL] [Abstract][Full Text] [Related]
11. Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies.
Obrzut SL; Koren AO; Mandelkern MA; Brody AL; Hoh CK; London ED
Nucl Med Biol; 2005 Nov; 32(8):869-74. PubMed ID: 16253812
[TBL] [Abstract][Full Text] [Related]
12. Human radiation dosimetry of [11C]MeAIB, a new tracer for imaging of system A amino acid transport.
Tolvanen T; Någren K; Yu M; Sutinen E; Havu-Aurén K; Jyrkkiö S; Asola M; Kotoneva E; Nuutila P; Minn H
Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1178-84. PubMed ID: 16721566
[TBL] [Abstract][Full Text] [Related]
13. Radiation dosimetry of [
Lee N; Oh I; Chae SY; Jin S; Oh SJ; Lee SJ; Koglin N; Berndt M; Stephens AW; Oh JS; Moon DH
Nucl Med Biol; 2019; 72-73():45-48. PubMed ID: 31330411
[TBL] [Abstract][Full Text] [Related]
14. Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies.
Mejia AA; Nakamura T; Masatoshi I; Hatazawa J; Masaki M; Watanuki S
J Nucl Med; 1991 Apr; 32(4):699-706. PubMed ID: 2013810
[TBL] [Abstract][Full Text] [Related]
15. Novel weight-based dose threshold for 18F-NaF PET-CT imaging using advanced PET-CT systems: a potential tool for reducing radiation burden.
Marafi F; Esmail A; Rasheed R; Alkandari F; Usmani S
Nucl Med Commun; 2017 Sep; 38(9):764-770. PubMed ID: 28723715
[TBL] [Abstract][Full Text] [Related]
16. Radiation dosimetry and biodistribution of the hypoxia tracer (18)F-EF5 in oncologic patients.
Lin LL; Silvoniemi A; Stubbs JB; Rengan R; Suilamo S; Solin O; Divgi C; Eskola O; Sorger JM; Stabin MG; Kachur A; Hahn SM; Grönroos TJ; Forsback S; Evans SM; Koch CJ; Minn H
Cancer Biother Radiopharm; 2012 Sep; 27(7):412-9. PubMed ID: 22897720
[TBL] [Abstract][Full Text] [Related]
17. Radiation dosimetry of O-(3-[18F]fluoropropyl)-L-tyrosine as oncologic PET tracer based on the mice distribution data.
Tang G; Tang X; Wang M; Luo L; Gan M
Appl Radiat Isot; 2004 Jan; 60(1):27-32. PubMed ID: 14687633
[TBL] [Abstract][Full Text] [Related]
18. Fluorine-18-fluoro-L-DOPA dosimetry with carbidopa pretreatment.
Brown WD; Oakes TR; DeJesus OT; Taylor MD; Roberts AD; Nickles RJ; Holden JE
J Nucl Med; 1998 Nov; 39(11):1884-91. PubMed ID: 9829576
[TBL] [Abstract][Full Text] [Related]
19. Biodistribution and radiation dosimetry of [18F]F-PEB in nonhuman primates.
Bélanger MJ; Krause SM; Ryan C; Sanabria-Bohorquez S; Li W; Hamill TG; Burns HD
Nucl Med Commun; 2008 Oct; 29(10):915-9. PubMed ID: 18769310
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and radiation dosimetry estimation of O-(2-[18F]fluoroethyl)-L-tyrosine as oncologic PET tracer.
Tang G; Wang M; Tang X; Luo L; Gan M
Appl Radiat Isot; 2003 Feb; 58(2):219-25. PubMed ID: 12573321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
